Biotech

Companies discussed: GlycoMimetics Inc (NASDAQ:GLYC), Cara Therapeutics Inc (NASDAQ:CARA), Advaxis, Inc (NASDAQ:ADXS) GlycoMimetics First up, GlycoMimetics Inc (NASDAQ:GLYC). GlycoMimetics just kicked off a phase 2 trial in patient with relapsed/refractory acute myeloid leukemia. The trial is the second part of a phase 1/2 in its lead oncology candidate, GMI1271, investigating the drug in combination...

Predictive Technology Group Inc (OTCMKTS:PRED) shares rose 14.18% on Friday to $1.43 after the company announced it will be renaming its LifeCode Genetics subsidiary. Predictive Technology Group Inc (OTCMKTS:PRED) will now call this subsidiary Predictive Diagnostics to realign its focus. "The name change of LifeCode Genetics to Predictive Diagnostics is to...

Lion Biotechnologies Inc (NASDAQ:LBIO) shares jumped 43.45% on Friday after the company announced its new President and CEO, Dr. Maria Fardis. Lion Biotechnologies Inc (NASDAQ:LBIO) shares rallied to $8.65, up $2.62 from its previous closing price, on Friday's US session. This was spurred by the announcement of the company's new CEO and...

Galena Biopharma Inc (NASDAQ:GALE) shares were up more than 19% on Tuesday to $2.16, nearing the top of its 52-week range at $2.39. Galena Biopharma Inc (NASDAQ:GALE) reported earnings per share of -$0.09 versus analysts estimates at -$0.06 at zero revenues. The company is focused on developing and commercializing targeted oncology...

Minerva Neurosciences Inc (NASDAQ:NERV) shares jumped 13.09% on June 1 to $13.91 after the company shared positive top-line results in clinical trials for its antidepressant drug candidate. Minerva Neurosciences Inc (NASDAQ:NERV) is a clinical-stage biopharmaceutical company that is focused on the development and commercialization of a portfolio of product candidates to treat...